AIM Stock Analysis: Buy, Sell, or Hold?
AIM - AIM ImmunoTech Inc.
$0.60
0.04 (8.18%)
▲
5d:
-13.96%
30d:
-13.87%
90d:
-47.35%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Mar 26, 2026
0d
Get Alerted When AIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AIM is currently trading at $0.59, which is considered oversold relative to its 30-day fair value range of $0.67 to $0.99.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.53, while resistance sits at $1.05. The stock is showing strong short-term momentum, up 8.2% recently.
Market Sentiment: AIM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $21.98 (+3593.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.53, while resistance sits at $1.05. The stock is showing strong short-term momentum, up 8.2% recently.
Market Sentiment: AIM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $21.98 (+3593.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.67 -
$0.99
Company Quality Score
47/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Strong upward momentum (+8.2%)
- BULLISH: Trading 3593.8% below Wall St target ($21.98)
- CAUTION: 5-day price weakness (-14.0%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.67 -
$0.99
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.53
Resistance Level
$1.05
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.01
Wall Street Target
$21.98
(+3593.8%)
Revenue Growth (YoY)
-53.3%
Share & Embed Analysis
Last updated: April 02, 2026 8:42 PM ET
Data refreshes hourly during market hours. Next update: 9:42 PM
Data refreshes hourly during market hours. Next update: 9:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AIM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
